An Open Label Study to Evaluate Daratumumab in Participants With Moderate to Severe Systemic Lupus Erythematosus

NCT04810754 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Charite University, Berlin, Germany

Collaborators